Finally, we have developed an in vitro mimicry assay by co-culturing several lung cancer cell lines with various expression levels of HER1, HER3, IGF1R and cMet to address heterogeneous expression of RTKs within tumors. This evidence concerns the gene ERBB3 and lung carcinoma.